Lapatinib Ditosylate is an antineoplastic agent and tyrosine kinase inhibitor used for the treatment of advanced or metastatic HER-negative breast cancer in patients. Reference standards of Lapatinib Ditosylate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Lapatinib Ditosylate
Catalogue No.:PA 12 1810000
CAS :
Molecular Formula : C43H42ClFN4O10S3
Molecular Weight : 925.46
N-((5-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-yl)methyl)-N-(2-(methylsulfonyl)ethyl)formamide
Catalogue No.:PA 12 1811000
Molecular Formula : C30H26ClFN4O5S
Molecular Weight : 609.07
Selatinib Hydrochloride
Catalogue No.:PA 12 1811001
Molecular Formula : C29H27Cl2FN4O3S
Molecular Weight : 601.52
N-(4-(Benzyloxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine Hydrochloride
Catalogue No.:PA 12 1811002
Molecular Formula : C29H29ClN4O4S
Molecular Weight : 565.09
Lapatinib Ditosylate (IPRS/05/19)
Catalogue No.:PA IPRS 05 19
Molecular Formula : NA
Molecular Weight : NA
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
